Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Michael O. Idowu"'
Autor:
Kranthi Kumar Chougoni, Haemin Park, Priyadarshan K. Damle, Travis Mason, Bo Cheng, Martin M. Dcona, Barbara Szomju, Mikhail G. Dozmorov, Michael O. Idowu, Steven R. Grossman
Publikováno v:
Oncogenesis, Vol 12, Iss 1, Pp 1-8 (2023)
Abstract There is a critical need to identify new therapeutic vulnerabilities in pancreatic ductal adenocarcinoma (PDAC). Transcriptional co-regulators C-terminal binding proteins (CtBP) 1 and 2 are highly overexpressed in human PDAC, and CRISPR-base
Externí odkaz:
https://doaj.org/article/ab4a0b9b5c2c463eaffaa9924dadd679
Autor:
Nicholas Koelsch, Faridoddin Mirshahi, Hussein F. Aqbi, Mulugeta Saneshaw, Michael O. Idowu, Amy L. Olex, Arun J. Sanyal, Masoud H. Manjili
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-18 (2023)
Abstract Abundance of data on the role of inflammatory immune responses in the progression or inhibition of hepatocellular carcinoma (HCC) has failed to offer a curative immunotherapy for HCC. This is largely because of focusing on detailed specific
Externí odkaz:
https://doaj.org/article/b445faca8cc44241a8a690ae830ee44f
Autor:
Jacqueline M. Grible, Patricija Zot, Amy L. Olex, Shannon E. Hedrick, J. Chuck Harrell, Alicia E. Woock, Michael O. Idowu, Charles V. Clevenger
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract The hormone prolactin (PRL) and its receptor (hPRLr) are significantly involved in breast cancer pathogenesis. The intermediate hPRLr (hPRLrI) is an alternatively-spliced isoform, capable of stimulating cellular viability and proliferation.
Externí odkaz:
https://doaj.org/article/4c18855c6cd74555a97c5428cf615799
Autor:
Hussein F. Aqbi, Cara Coleman, Melika Zarei, Saeed H. Manjili, Laura Graham, Jennifer Koblinski, Chunquing Guo, Yibin Xie, Georgi Guruli, Harry D. Bear, Michael O. Idowu, Mehran Habibi, Xiang-Yang Wang, Masoud H. Manjili
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-15 (2020)
Abstract Background Although breast cancer mortality is a result of distant recurrences associated with the establishment of tumor dormancy, current clinical practice guidelines recommend a wait and watch approach for tumor recurrences. This is becau
Externí odkaz:
https://doaj.org/article/76d63ae0d42147fd870e77928dba6454
Autor:
Rebeca Mayo, Javier Crespo, Ibon Martínez‐Arranz, Jesus M Banales, Mayte Arias, Itziar Mincholé, Rocío Aller de la Fuente, Raúl Jimenez‐Agüero, Cristina Alonso, Daniel A. de Luis, Libor Vitek, Jan Stritesky, Joan Caballería, Manuel Romero‐Gómez, Antonio Martín‐Duce, Jose Maria Mugüerza Huguet, José Ignacio Busteros‐Moraza, Michael O. Idowu, Azucena Castro, M. Luz Martínez‐Chantar, Pablo Ortiz, Radan Bruha, Shelly C. Lu, Pierre Bedossa, Mazen Noureddin, Arun J. Sanyal, José M. Mato
Publikováno v:
Hepatology Communications, Vol 2, Iss 7, Pp 807-820 (2018)
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes, ranging from simple hepatic steatosis or nonalcoholic fatty liver (NAFL) to nonalcoholic steat
Externí odkaz:
https://doaj.org/article/3db3e565d647480a965ad1c11a5f01be
Autor:
Leandro M. Martinez, Valentina Robila, Nicholas M. Clark, Wei Du, Michael O. Idowu, Melanie R. Rutkowski, Paula D. Bos
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Ductal carcinoma in situ (DCIS) is a non-obligate precursor of breast cancer, and it only progresses to invasive breast cancer in around 40% of patients. While immune infiltrates have been observed in these early cancer lesions, their potential progn
Externí odkaz:
https://doaj.org/article/8ff76fd244e84430b3b5ee682c73df14
Autor:
Tareq Saleh, Liliya Tyutynuk-Massey, Emmanuel K. Cudjoe, Michael O. Idowu, Joseph W. Landry, David A. Gewirtz
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
In addition to promoting various forms of cell death, most conventional anti-tumor therapies also promote senescence. There is now extensive evidence that therapy-induced senescence (TIS) might be transient, raising the concern that TIS could represe
Externí odkaz:
https://doaj.org/article/0b9798c39d2e4f999d0aff471e35555f
Autor:
Austin Blackburn Wiles MD, Michael O. Idowu MD, MPH, Charles V. Clevenger MD, PhD, Celeste N. Powers MD, PhD
Publikováno v:
Academic Pathology, Vol 5 (2018)
Academic pathologists perform clinical duties, as well as valuable nonclinical activities. Nonclinical activities may consist of research, teaching, and administrative management among many other important tasks. While clinical duties have many clear
Externí odkaz:
https://doaj.org/article/37f16757d2ec4ed0b786a318e7c251cc
Autor:
Rania Bassiouni, Michael O. Idowu, Lee D. Gibbs, Valentina Robila, Pamela J. Grizzard, Michelle G. Webb, Jiarong Song, Ashley Noriega, David W. Craig, John D. Carpten
Publikováno v:
Cancer Res
Triple-negative breast cancer (TNBC) is an aggressive disease that disproportionately affects African American (AA) women. Limited targeted therapeutic options exist for patients with TNBC. Here, we employ spatial transcriptomics to interrogate tissu
Autor:
Jennifer E. Koblinski, Nicholas P. Farrell, Kazuaki Takabe, Eriko Katsuta, Larisa Litovchick, Bin Hu, Madhavi Puchalapalli, Michael O. Idowu, Mayuri Shende, Vita Kraskauskiene, Pam J. Gigliotti, Joseph B. McGee Turner, Mikhail G. Dozmorov, J. Chuck Harrell, Mohammad A. Alzubi, Tia H. Turner, Samantha J. Katner, Erica J. Peterson, James D. Hampton
Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targetable biomarkers. TNBC is known to be most aggressive and when metastatic is often drug-resistant and uncurable. Biomarkers predicting response to therapy improve treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62cc3ab448dff231d3ed792829c70fad
https://doi.org/10.1158/1535-7163.c.6543516.v1
https://doi.org/10.1158/1535-7163.c.6543516.v1